Author

Ryan K. Spencer

Eli Lilly (United States)ORCID 0000-0002-1043-3913Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:proteomics· 1

Frequent Co-Authors

Alec Lourenço· 1 shared Arjuna M. SubramanianiD· 1 shared Eric D. ChowiD· 1 shared Jiapei MiaoiD· 1 shared Matt W. ThomsoniD· 1 shared Michael A. AnayaiD· 1 shared William Fu· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

Alec Lourenço

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

BioengineeringbioRxivPreprintDec 20, 2024

Protein CREATE enables closed-loop design of de novo synthetic protein binders

Alec Lourenço, Arjuna M. Subramanian, Ryan K. Spencer…·Matt W. Thomson

Protein CREATE generates and tests synthetic protein binders using a closed-loop computational-experimental pipeline, identifying novel binders and binding features.

3 citations

proteomicsdeep learning

𝕏 PostBluesky